Thursday, 20 July 2017

Irvine Pharma to set up manufacturing facility in China

04 November 2014 | News | By BioSpectrum Bureau

Irvine Pharma to set up manufacturing facility in China

The company plans to open a new facility in Hangzhou, China by first quarter of 2015

The company plans to open a new facility in Hangzhou, China by first quarter of 2015

Singapore: US based Irvine Pharmaceutical Services, a contract manufacturing service provider, plans to open a new facility in Hangzhou, China to support the Asian market.

The 115,000 sqft facility is scheduled to be fully operational in the first quarter of 2015. Dr Assad J Kazeminy, CEO and founder of the company said, "Irvine is responding to the rising needs of large multi-national pharmaceutical companies that are looking for contract organizations overseas that include robust cGMP quality infrastructure and technical expertise. Irvine will now have a local presence and a strong understanding of the local market to offer the region high quality analytical support."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls